India to Philippines: Paclitaxel Export Trade Route
India has recorded 190 verified shipments of Paclitaxel exported to Philippines, representing a combined trade value of $2.5M USD. This corridor is served by 27 active Indian exporters, with an average shipment value of $13.0K USD. The leading Indian exporter is PRIME PHARMACEUTICALS PRIVATE LIMITED, which accounts for 17% of total export value with 12 shipments worth $424.9K USD. On the buying side, TO THE ORDER OF is the largest importer in Philippines with $341.8K USD in purchases. The top 3 suppliers — PRIME PHARMACEUTICALS PRIVATE LIMITED, CELON LABORATORIES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD. — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Paclitaxel corridor is one of India's established pharmaceutical export routes, with 190 shipments documented worth a combined $2.5M USD. The route is dominated by PRIME PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 17% of all export value, reflecting the consolidated nature of India's paclitaxel manufacturing sector.
Across 27 active suppliers, the average shipment value stands at $13.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (60%) and air (40%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July-September, with an average transit time of 12 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #5 among India's top paclitaxel export destinations globally.
On the import side, key buyers of Indian paclitaxel in Philippines include TO THE ORDER OF, VE PHARMA INC, AMBICA INTERNATIONAL CORPORATION and 48 others. TO THE ORDER OF is the single largest importer with 9 shipments valued at $341.8K USD.
